# Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

> **NCT00136526** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 30 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Docetaxel and Diethylstilbestrol (DES)

## Key facts

- **NCT ID:** NCT00136526
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136526, "Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00136526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*